In episode 5 of an ongoing series of sharing sessions between a physician and patient, Anna Christina L. dela Cruz, MD, and Rhonda, who is living with chronic hepatitis B, discuss what to do when the decision to start treatment is not clear because of borderline ALT test results and HBV DNA levels. Their conversation highlights a need for patient education and shared decision-making.Presenter:Anna Christina L. dela Cruz, MDAssociate ProfessorDivision of Digestive Diseases and NutritionDepartment of Internal MedicineUniversity of KentuckyLexington, KentuckyContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program:https://bit.ly/3u196yK Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related